Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.53 -0.82 (-5.35%)
As of: Oct 1, 2026 · 3:59 PM EDT

Cullinan Therapeutics (CGEM) Return on Assets [ROA] (2021 - 2026)

Updated

Cullinan Therapeutics (CGEM) recorded Return on Assets [ROA] of -53.39% in Q2 2026, down 15.80 percentage points from -37.59% a year earlier and down 1.46 percentage points from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Cullinan Therapeutics reported Return on Assets [ROA] of -41.09%, down 10.79 percentage points from FY2024.

  • Annual Return on Assets [ROA] has declined for three straight years, with a four-year change of -20.39 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -30.30% in FY2024 (-0.63 pp), -29.68% in FY2023 (-51.55 pp), 21.88% in FY2022 (+42.58 pp) and -20.70% in FY2021.
  • The Q2 2026 figure is the lowest quarterly Return on Assets [ROA] in data going back to Q1 2021.
  • On a year-over-year basis, Return on Assets [ROA] has declined for six consecutive quarters, with an average year-over-year change of -9.86 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 33.69 percentage points in Q4 2022, against a drop of 50.22 percentage points in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -51.93% (Q1 2026), -47.16% (Q4 2025) and -43.17% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Cullinan Therapeutics 987.71 Mn 987.71 Mn - -53.39%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -53.39%
Mar 31, 2026 -51.93%
Dec 31, 2025 -47.16%
Sep 30, 2025 -43.17%
Jun 30, 2025 -37.59%
Mar 31, 2025 -29.75%
Dec 31, 2024 -26.28%
Sep 30, 2024 -21.81%
Jun 30, 2024 -25.49%
Mar 31, 2024 -28.77%
Dec 31, 2023 -31.69%
Sep 30, 2023 -30.81%
Jun 30, 2023 -27.45%
Mar 31, 2023 11.88%
Dec 31, 2022 18.53%
Sep 30, 2022 15.89%
Jun 30, 2022 19.68%
Mar 31, 2022 -18.70%
Dec 31, 2021 -15.16%
Sep 30, 2021 -13.60%
API Access

Cullinan Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CGEM&period=max&api_key=YOUR_API_KEY